{"id":136,"date":"2023-02-13T15:14:34","date_gmt":"2023-02-13T15:14:34","guid":{"rendered":"http:\/\/192.168.10.30\/?page_id=136"},"modified":"2023-02-13T15:14:34","modified_gmt":"2023-02-13T15:14:34","slug":"torpedo","status":"publish","type":"page","link":"https:\/\/rttrialsqa.org.uk\/?page_id=136","title":{"rendered":"Torpedo"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer.<\/p>\n\n\n\n

Trial summary:<\/h2>\n\n\n\n

The TORPEdO trial compares toxicity outcomes at 12 months for patients with oropharyngeal cancer, randomised to either photons (IMRT) or protons (IMPT). Randomisation has a 2:1 weighting in favour of proton treatment. A total of 183 patients will be recruited.<\/p>\n\n\n\n

RT QA summary:<\/h2>\n\n\n\n

All QA activity will be streamlined with previous trial QA, where applicable. Please contact the RTTQA Group directly using the contact details below to discuss<\/em><\/p>\n\n\n\n\n\n\n\t\n\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t
QA Process<\/th>QA Activity<\/th>Required for Trial<\/th>Additional Details<\/th>\n<\/tr>\n<\/thead>\n
Pre-Accrual<\/td>Facility Questionnaire<\/td>\"\"<\/td><\/td>\n<\/tr>\n
Outlining Benchmark Case<\/td>\"\"<\/td><\/td>\n<\/tr>\n
Planning Benchmark Case<\/td>\"\"<\/td><\/td>\n<\/tr>\n
Dummy Run<\/td><\/td><\/td>\n<\/tr>\n
During Accrual<\/td>Individual Case Review<\/td>\"\"<\/td>Prospective: Outlining for all patients, planning for first case.
\nRetrospective: all patients
\n<\/td>\n<\/tr>\n
Data collection<\/td>\"\"<\/td>All plans, replans and CBCT data<\/td>\n<\/tr>\n
Dosimetry <\/td><\/td>\"\"<\/td><\/td>\n<\/tr>\n
QA Streamlining<\/td><\/td>\"\"<\/td>CompARE, NIMRAD, DARS and PATHOS<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n

RTTQA contact: <\/strong>torpedoqa.enh-tr@nhs.net
Chief investigator: <\/strong>Dr David Thomson (The Christie NHS Foundation Trust)
Sponsor: <\/strong>The Institute of Cancer Research (TORPEdO-icrctsu@icr.ac.uk)
Funder:<\/strong> Cancer Research UK<\/p>\n","protected":false},"excerpt":{"rendered":"

A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer. Trial summary: The TORPEdO […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-136","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=\/wp\/v2\/pages\/136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=136"}],"version-history":[{"count":1,"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=\/wp\/v2\/pages\/136\/revisions"}],"predecessor-version":[{"id":138,"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=\/wp\/v2\/pages\/136\/revisions\/138"}],"wp:attachment":[{"href":"https:\/\/rttrialsqa.org.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}